//
Jia Chen
Yiyang Ding
Xi Zhang
Erlie Jiang
Lin Liu
He Huang
Jiong Hu
Jishi Wang
Yanming Zhang
Myriam Labopin
Irma Khvedelidze
Emmanuelle Polge
Arnon Nagler
Mohamad Mohty
Depei Wu
Norbert Claude Gorin
Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang City, China
on behalf of the global committee and the acute leukemia working party of the EBMT, Paris, China
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
EBMT Global Committee and Acute Leukemia Working Party, Hopital Saint-Antoine APHP and Sorbonne University, Paris, China
Department of Hematology, Xinqiao Hospital, The Third Military Medical University, Chongqing, China
Department of Hematology, Huai'an Second People's Hospital, Huai'an, China
The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
China
Israel
France
N/A
Autoimmune (AI)
Graft-versus-host disease
N/A
N/A
N/A
Global
NA
N/A
N/A
N/A